Literature DB >> 18199524

Cannabinoids for cancer treatment: progress and promise.

Sami Sarfaraz1, Vaqar M Adhami, Deeba N Syed, Farrukh Afaq, Hasan Mukhtar.   

Abstract

Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199524     DOI: 10.1158/0008-5472.CAN-07-2785

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  79 in total

1.  Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

Authors:  Anju Preet; Zahida Qamri; Mohd W Nasser; Anil Prasad; Konstantin Shilo; Xianghong Zou; Jerome E Groopman; Ramesh K Ganju
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-19

2.  Cannabinoids attenuate cancer pain and proliferation in a mouse model.

Authors:  Negin Saghafi; David K Lam; Brian L Schmidt
Journal:  Neurosci Lett       Date:  2010-11-19       Impact factor: 3.046

Review 3.  Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers.

Authors:  Shreyas Gandhi; Gaurav Vasisth; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-04-11       Impact factor: 1.862

4.  Peroxisome proliferator-activated receptor-γ agonist-mediated inhibition of cell growth is independent of apoptosis in human epidermoid carcinoma A431 cells.

Authors:  Qian Li; Yu-Sheng Peng; Ping-Jiao Chen; Meng-Lei Wang; Can Cao; Hao Xiong; Jing Zhang; Ming-Hua Chen; Xue-Biao Peng; Kang Zeng
Journal:  Oncol Lett       Date:  2018-02-28       Impact factor: 2.967

Review 5.  Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Authors:  Amber Cintosun; Irene Lara-Corrales; Elena Pope
Journal:  Clin Drug Investig       Date:  2020-04       Impact factor: 2.859

Review 6.  The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

Authors:  Sean D McAllister; Liliana Soroceanu; Pierre-Yves Desprez
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-28       Impact factor: 4.147

7.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

Review 8.  The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.

Authors:  Tamás Bíró; Balázs I Tóth; György Haskó; Ralf Paus; Pál Pacher
Journal:  Trends Pharmacol Sci       Date:  2009-07-14       Impact factor: 14.819

9.  Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.

Authors:  Kristin Gustafsson; Birgitta Sander; Jacek Bielawski; Yusuf A Hannun; Jenny Flygare
Journal:  Mol Cancer Res       Date:  2009-07       Impact factor: 5.852

10.  Towards the use of non-psychoactive cannabinoids for prostate cancer.

Authors:  Pál Pacher
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.